BOLD Longevity Growth Fund has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Matchpoint Therapeutics's $150M Series B+ round in October 2026, alongside T1D Fund, Sanofi Ventures, Norwest Venture Partners and 6 others. That company is in Health and bio.

What BOLD Longevity Growth Fund invests in

• Health and bio · 1 · 100%
• Education · 1 · 100%

How BOLD Longevity Growth Fund invests

Share is of the 1 round on Recent Funding that name BOLD Longevity Growth Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

BOLD Longevity Growth Fund portfolio companies

• MMatchpoint Therapeutics$150MSeries B+ · Oct 2026

Most frequent co-investors

• NNorwest Venture Partners1 shared round · last Oct 7, 2026
• SSanofi Ventures1 shared round · last Oct 7, 2026
• IInvus1 shared round · last Oct 7, 2026
• DDigitalis Ventures1 shared round · last Oct 7, 2026
• TT1D Fund1 shared round · last Oct 7, 2026
• NNextech Invest1 shared round · last Oct 7, 2026
• BBB Biotech1 shared round · last Oct 7, 2026
• AAtlas Venture1 shared round · last Oct 7, 2026
• AAccess Biotechnology1 shared round · last Oct 7, 2026

Similar investors

• CChile Ventures1 company · 1 deal in 12 mo
• LLumina Impact Ventures1 company
• AArmilar Venture Partners2 companies · 1 deal in 12 mo
• EEducapital2 companies · 1 deal in 12 mo
• GGutter Capital2 companies · 1 deal in 12 mo
• VVitalStage Ventures2 companies · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists BOLD Longevity Growth Fund, which is a subset of its real portfolio. API: /api/v1/investors/bold-longevity-growth-fund (get a free API key). More: the most active VC firms and new venture capital funds.